Stock-Based Compensation (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
| Share-Based Payment Arrangement [Abstract] |
|
| Stock Options, Valuation Assumptions |
The weighted average assumptions used in our Black-Scholes option pricing model for options granted in 2023 were as follows: | | | | | | | | | | | 2023 | | Dividend yield | | 0.71% - 0.83% | | Expected volatility | | 58.16 | % | | Risk-free interest rate | | 3.60% - 4.10% | | Expected term in years | | 6.0 years |
|
| Stock Options, Activity |
The following table summarizes activity related to stock options during 2025: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Number of Options | | Weighted- Average Exercise Price Per Share | | Aggregate Intrinsic Value (thousands) | | Weighted Average Remaining Term (Years) | Outstanding at December 31, 2024 | | 199,284 | | | $ | 113.41 | | | | | | | Granted | | — | | | — | | | | | | | Exercised | | — | | | — | | | | | | | Forfeited or expired | | (32,134) | | | 89.14 | | | | | | Outstanding at December 31, 2025 | | 167,150 | | | $ | 118.08 | | | $ | — | | | 4.3 years | Vested and Expected to vest as of December 31, 2025 | | 167,150 | | | $ | 118.08 | | | $ | — | | | 4.3 years | Exercisable at December 31, 2025 | | 154,627 | | | $ | 121.32 | | | $ | — | | | 4.1 years |
A summary of the status and changes of unvested stock options and the related average price per share follows: | | | | | | | | | | | | | | | | | Number of Options | | Weighted- Average Grant Date Fair Value | Outstanding unvested as of December 31, 2024 | | 38,132 | | | $ | 41.23 | | | Granted | | — | | | — | | | Vested | | (13,303) | | | 38.59 | | | Forfeited | | (12,306) | | | 42.46 | | Outstanding unvested as of December 31, 2025 | | 12,523 | | | $ | 42.82 | |
|
| Schedule of Nonvested Restricted Stock Units Activity |
A summary of the status and changes of unvested but outstanding shares subject to RSU awards for employees and the related average price per share follows: | | | | | | | | | | | | | | | | | Number of Shares | | Weighted- Average Grant Date Fair Value | Outstanding unvested as of December 31, 2024 | | 359,915 | | | $ | 26.10 | | | Granted | | 368,058 | | | 11.90 | | | Cancelled | | (132,597) | | | 22.00 | | | Vested | | (111,065) | | | 26.92 | | Outstanding unvested as of December 31, 2025 | | 484,311 | | | $ | 16.24 | |
|
| Share-Based Payment Arrangement, Restricted Stock Unit, Activity |
The following table summarizes RSU and DRSU activity during 2025 for our non-employee directors: | | | | | | | | | | | | | | | | | Number of Shares | | Weighted- Average Grant Date Fair Value | Outstanding as of December 31, 2024 | | 38,948 | | | $ | 24.19 | | | Granted | | 95,338 | | | 7.13 | | | Vested and delivered | | (1,107) | | | 50.00 | | Outstanding vested and deferred as of December 31, 2025 | | 133,179 | | | $ | 11.76 | |
|
| Schedule of Nonvested Performance-Based Units Activity |
The following table summarizes the activity related to PSUs during 2025: | | | | | | | | | | | | | | | | | Number of Shares | | Weighted- Average Grant Date Fair Value | Outstanding as of December 31, 2024 | | 175,794 | | | $ | 21.75 | | | Granted | | 170,241 | | | 6.10 | | | Vested | | — | | | — | | | Forfeited | | (85,454) | | | 18.79 | | Outstanding as of December 31, 2025 | | 260,581 | | | $ | 12.49 | |
|
| Schedule of Deferred Share Units |
The following table summarizes DSU activity during 2025: | | | | | | | | | | | | | | | | | Number of Shares | | Weighted- Average Grant Date Fair Value | Outstanding as of December 31, 2024 | | 53,151 | | | $ | 39.51 | | | Granted | | 49,564 | | | 11.14 | | | Distributed | | (3,347) | | | 15.84 | | Outstanding vested and deferred as of December 31, 2025 | | 99,368 | | | $ | 26.16 | |
|